Back
March 25, 2022

VSS Scientific Updates During Pandemic Times #12

Goal: Our newsletter aims at providing regular updates on the science and the truth behind the current pandemic. We are dedicated to bringing the real science to the table and sharing how the truth invalidates the current narrative, for which scientific evidence is now increasingly lacking. We’ll provide an update on a (semi-)weekly basis, on Mondays and/or Fridays. We sincerely hope this newsletter will contribute to raising awareness about the consequences of human intervention in this pandemic, particularly of mass vaccination, from both an individual and public health perspective.

1. DNA Transcribed from Pfizer mRNA Vaccine Contains Mutant gp130 Tumor Gene

“The sequence of mutated gp130 genes, found in the DNA reverse transcribed from Pfizer Covid vaccine, does not mean that it will necessarily cause cancer, does not mean that it was added to Pfizer vaccine intentionally to cause harm, does not mean that it is even expressed as a gp130 protein, as expression of genes depends on cellular context. What it DOES mean is that we need to look at this closely.”

https://igorchudov.substack.com/p/dna-transcribed-from-pfizer-mrna?s=r

2. Record Surge of COVID-19 Case sand Deaths in Heavily Vaxxed South Korea

“Not only one of the most vaccinated peoples in the world, but the population of South Korea are also one of the most boosted. Yet SARS-CoV-2, the virus behind COVID-19, rages at record levels leading to record deaths.”

https://trialsitenews.com/record-surge-of-covid-19-cases-and-deaths-in-heavily-vaxxed-south-korea-whats-going-on/

3. Time-Dependent Changes in Death Reports and the Sex Ratio in the Safety Surveillance of SARS-CoV-2 Vaccination

“In conclusion, we found an early peak of death reports in older individuals in the days following BNT162b2 mRNA vaccination in Japan,the US, and Europe. We also observed time-dependent changes in the sex ratio of the deceased after the vaccination reported in Japan.These findings suggest that we may be unaware of specific characteristics that increase susceptibility to the serious adverse events of SARS-CoV-2 vaccination. The careful and continuous monitoring of vaccine safety is warranted.”

https://www.cureus.com/articles/88293-time-dependent-changes-in-death-reports-and-the-sex-ratio-in-the-safety-surveillance-of-sars-cov-2-vaccination-in-japan-the-united-states-and-european-countries

4. Is South Africa the Post-Covid Digital Surveillance Launchpad for the World?

“… we must keep a very careful eye on what happens next in South Africa and do what we can to support the small band of doctors, practitioners and awakened activists that are trying to derail the government’s attempts to control a population through outside pressure and funding.””

https://www.anhinternational.org/news/is-south-africa-the-post-covid-digital-surveillance-launchpad-for-the-world/

5. European Commission Seeking Feedback Regarding EU Digital COVID Certificate

“This adopted act is open for feedback for a minimum period of 8 weeks. All feedback received will be summarized by the European Commission and presented to the European Parliament and Council with the aim of feeding into the legislative debate.”

https://ec.europa.eu/info/law/better-regulation/have-your-say/initiatives/13375-Extension-of-EU-Digital-COVID-Certificate-Regulation_en

Support our work
DONATE
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.

Email: info@voiceforscienceandsolidarity.org

Recent Posts
December 19, 2024

Dynamics of SARS-CoV-2 in highly C-19 vaccinated populations in a nutshell

Read
December 2, 2024

Are Newly Emerging Saltation Variants the Desperate Harbingers of an Imminent Surge in COVID-19 Case Fatalities in Highly C-19 Vaccinated Populations?

Read
November 23, 2024

Bird Flu Gain-of-Function Study Fueling Vaccine Development, Fears of Human Transmission

Read
Voices for Science and solidarity, © 2023